Hikal Limited (BOM:524735)
India · Delayed Price · Currency is INR 212.70
-5.20 (-2.39%)
At close: Aug 17, 2026
Hikal Market Cap
Hikal has a market cap or net worth of 26.87 billion as of August 17, 2026. Its market cap has decreased by -14.85% in one year.
Market Cap
26.87B
Enterprise Value
33.57B
Revenue
17.35B
Ranking
n/a
PE Ratio
n/a
Stock Price
212.70
ChartMarket Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 26.87B, an increase of 1,879.60%. That is a compound annual growth rate of 13.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 26.87B | -3.97% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Morepen Laboratories | 46.15B |
| Gufic Biosciences | 42.24B |
| Novartis India | 39.18B |
| Unichem Laboratories | 37.93B |
| Kwality Pharmaceuticals | 35.74B |
| Fredun Pharmaceuticals | 25.60B |
| Venus Remedies | 23.88B |
| Shukra Pharmaceuticals | 18.21B |